Superlab Suisse opens 5000 square meters lab space in Basel

For life sciences and biotech companies, access to affordable dedicated lab spaces is hard to come by. Labs are expensive to build and operate. A new alternative is being offered by Superlab Suisse, a leading provider of innovative laboratory and research spaces that this week announced the grand opening of its newest facility in Basel. Forging ahead with its successful partnership with Swiss Prime Site, Superlab Suisse becomes the largest private lab space in Switzerland with this new facility. 

Opening in July 2024, following the success of its Lausanne location supported by Biopôle and Innovaud, the expansion marks a significant milestone in Superlab Suisse's mission to provide research infrastructure to Switzerland's dynamic life sciences sector.

The new facility, nestled within the bustling Stücki Park with neighbours like Tech Park Basel, Lonza, Medartis, NBE, and Boehringer Ingelheim, offers ready-to-use laboratory spaces equipped with the latest technology and essential operational support services, allowing teams to channel their resources into scientific research rather than lab operations. Spanning over 4770 square metres, it promises to be a nucleus of scientific collaboration and breakthrough, redefining laboratory services in Basel. 

"We are thrilled to bring Superlab Suisse's innovative platform to Basel, the city of Pharma," says Zhang Xi, CEO of Superlab Suisse. “Our holistic solution frees scientists from operations headaches, so they can save time and focus on science. We service, you discover, is our mantra”.

Superlab Suisse's serviced BSL1 and BSL2 labs provide a new industry standard of lab solution. Users in one location such as Basel also gain access to facilities in Lausanne and other locations. By delivering ready to move in lab solutions for life science companies of all sizes, including startups, scale-ups, and corporates, Superlab Suisse eliminates the hurdles of lab construction and operation. One of the first companies to secure their space at the opening is Skyhawk Therapeutics, a US-Swiss company developing small molecule therapeutics that modify RNA expression. 

In addition to the Basel location, Superlab Suisse continues its commitment to innovation with plans for a third site in Zurich Schlieren. This new facility, scheduled to open in March 2025, will cater to the diverse needs of start-ups, spin-offs, and established companies in the life sciences sector, further solidifying Superlab Suisse's position as a leader in laboratory-as-a-service solutions. Superlab plans to expand to more cities in Europe, the US, and Asia, embodying a borderless lab concept.

Emmanuel Savioz, CEO & Chairman, Tigen Pharma commented: “Superlab is a great place to work in a vibrant scientific community. Our team at Tigen can focus on growth, supported by state-of-the-art facilities, latest equipment and a competent and fun Superlab team to support on-site”.

(Press release / SK)